What is the equivalent dose of fluoxetine (Prozac) for a patient taking 100mg of sertraline?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 20, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Sertraline 100mg to Fluoxetine Dose Equivalency

Based on the highest quality evidence from randomized controlled trials, sertraline 100mg is approximately equivalent to fluoxetine 40mg daily. 1

Evidence-Based Dose Conversion

The most rigorous systematic analysis of antidepressant dose equivalency, which examined 83 randomized controlled trials with over 14,000 participants, established that sertraline 98.5mg/day is equivalent to fluoxetine 40mg/day. 1 This translates to a conversion ratio of approximately 2.5:1 (sertraline:fluoxetine).

Practical Application

  • For a patient taking sertraline 100mg, the equivalent fluoxetine dose is 40mg daily. 1
  • This conversion is based on weighted mean dose ratios from flexible-dose comparative trials, making it the most evidence-based approach available. 1

Important Switching Considerations

Pharmacokinetic Differences

  • Fluoxetine has an exceptionally long half-life (1-3 days for parent compound, 4-16 days for active metabolite norfluoxetine), taking 5-7 weeks to reach steady-state, which creates unique challenges when switching from sertraline. 2
  • Sertraline has a 24-hour half-life with predictable, dose-proportional pharmacokinetics, allowing steady-state within 1 week. 2

Recommended Switching Strategy

  • Start fluoxetine 40mg daily the day after the last sertraline dose, as the rapid clearance of sertraline (gone within 5-7 days) requires immediate initiation of the replacement SSRI. 2
  • Monitor closely for the first 2-4 weeks as fluoxetine gradually reaches therapeutic levels over several weeks due to its prolonged half-life. 2

Critical Safety Warnings

CYP2D6 Considerations

  • If the patient is a CYP2D6 poor metabolizer, they may experience 3.9 to 11.5-fold higher fluoxetine levels even at standard doses, significantly increasing toxicity risk. 2, 3
  • Consider starting at fluoxetine 10mg daily in known poor metabolizers, as the FDA has issued safety warnings about QT prolongation risk in this population. 3
  • Unexpected adverse effects at standard fluoxetine doses should prompt CYP2D6 testing. 2

Monitoring Requirements

  • Watch for discontinuation syndrome symptoms during the first week, though less likely with the immediate fluoxetine start. 2
  • Monitor for serotonin syndrome risk in the first 24-48 hours, particularly if the patient takes other serotonergic medications. 2
  • Assess for return of depressive or anxiety symptoms at weeks 2,4, and 8, as therapeutic effect should be maintained throughout the switch if dose equivalency is appropriate. 2

Clinical Context from Comparative Trials

Multiple head-to-head trials demonstrated comparable efficacy between sertraline 50-100mg and fluoxetine 20-40mg in treating major depression, supporting the dose equivalency calculations. 4, 5, 6 Response rates were similar between groups, with 69% for sertraline and 67% for fluoxetine in one large trial. 4

References

Guideline

Fluoxetine to Sertraline Conversion

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Increased Anxiety After Fluoxetine Dose Increase

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Research

A double-blind comparison of sertraline and fluoxetine in the treatment of major depressive episode in outpatients.

European psychiatry : the journal of the Association of European Psychiatrists, 1999

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.